©The Author(s) 2025.
World J Gastrointest Endosc. Apr 16, 2025; 17(4): 101998
Published online Apr 16, 2025. doi: 10.4253/wjge.v17.i4.101998
Published online Apr 16, 2025. doi: 10.4253/wjge.v17.i4.101998
Table 4 Performance of Franseen needle for the diagnosis of pancreatic malignancy
| Diagnostic method | Disease | ||
| Pancreatic malignancy1 (n = 47) | Chronic pancreatis (n = 3) | Total | |
| Positive for malignancy | 43 | 1 | 44 |
| Negative for malignancy | 4 | 2 | 6 |
| Total | 47 | 3 | 50 |
| 95%CI | |||
| Sensitivity | 0.91 (0.83-0.98) | ||
| Specificity | 0.67 (0.09-0.98) | ||
| PPV | 0.98 (0.88-1.00) | ||
| NPV | 0.33 (0.04-0.78) | ||
| Accuracy | 0.90 (0.78-0.97) | ||
- Citation: Paduani GF, Felipe LM, De Paulo GA, Lenz L, Martins BC, Matuguma SE, Safatle-Ribeiro AV, De Mello ES, Maluf-Filho F. Prospective randomized study comparing Franseen 22-gauge vs standard 22-gauge needle for endoscopic ultrasound guided sampling of pancreatic solid lesions. World J Gastrointest Endosc 2025; 17(4): 101998
- URL: https://www.wjgnet.com/1948-5190/full/v17/i4/101998.htm
- DOI: https://dx.doi.org/10.4253/wjge.v17.i4.101998